Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Hematologic Neoplasms 4Mycoses 3Leukemia 3Leukemia, Myeloid, Acute 2Invasive Fungal Infections 2Infections 2Non-Melanoma Skin Carcinoma 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Lymphoma 1Haematological Malignancies 1Bronchiolitis Obliterans Syndrome 1B-cell Malignancies 1

Interventions

fludarabine phosphate 16Peripheral Blood Stem Cell Transplantation 16Cyclophosphamide 16Mycophenolic Acid 14Whole-Body Irradiation 13Cyclosporine 12Busulfan 12Tacrolimus 11Methotrexate 10Antilymphocyte Serum 9Etoposide 7Cyclosporins 7Melphalan 6Sirolimus 5Radiotherapy 5Cytarabine 5Filgrastim 4Cord Blood Stem Cell Transplantation 4ruxolitinib 3Rituximab 3Granulocyte Colony-Stimulating Factor 3Alemtuzumab 3thymoglobulin 2sargramostim 2Pentostatin 2Methylprednisolone 2Flow Cytometry 2Carmustine 2Carboplatin 2veliparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Myelodysplastic-Myeloproliferative Diseases × Voriconazole × Clear all
NCT00075803 2023-01-04

BMT CTN 0101

Medical College of Wisconsin

Phase 3 Completed
600 enrolled 22 charts
LymphoidMyeloidOther hematologic neoplasm

Infections, Leukemia, Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡